July 12, 2016
Kyorin Pharmaceutical and Kaken Pharmaceutical have basically agreed to enter into a copromotion arrangement in Japan for desloratadine, an anti-allergy drug anticipated to hit the market by the end of the year. The two companies said on July 11 that...read more